Skip to main content
Top
Published in: BMC Medicine 1/2013

Open Access 01-12-2013 | Research article

The thrombophilic network of autoantibodies in celiac disease

Authors: Aaron Lerner, Nancy Agmon-Levin, Yinon Shapira, Boris Gilburd, Sandra Reuter, Idit Lavi, Yehuda Shoenfeld

Published in: BMC Medicine | Issue 1/2013

Login to get access

Abstract

Background

Celiac disease is a life-long autoimmune condition, affecting genetically susceptible individuals that may present with thromboembolic phenomena. This thrombophilia represents a puzzle with multiple constituents: hyperhomocysteinemia, B12 and\or folate deficiency, methylenetetrahydrofolate reductase mutations, and protein C and S deficiency due to vitamin K deficiency. However, the well known thrombogenic factors, antiphosphatidylserine/prothrombin and antiprothrombin have never been explored in celiac disease.

Methods

The serum autoantibody levels were determined in 248 individuals, classified into three groups. Group 1 comprised 70 children with definitive celiac disease (age: 7.04 ±4.3 years, male to female ratio 1.06) and group 2 comprised 88 normal children (age: 6.7 ±4.17 years, male to female ratio 0.87), representing controls. The pediatric populations were compared to group 3, which included 90 adults who were family members (parents) of group 1 (age: 34.6 ±11.35 years, male to female ratio 1.2). Antibodies were checked by enzyme-linked immunosorbent assay.

Results

Mean optical density levels of serum antiphosphatidylserine/prothrombin immunoglobulin G antibodies were 32.4 ±19.4, 3.6 ±2.5 and 16.1 ±15.8 absorbance units in groups 1, 2 and 3 respectively (P <0.0001), with 45.7%, 0% and 7.8% of groups 1, 2 and 3 respectively positive for the antibody (P <0.01). Mean optical density levels of serum antiphosphatidylserine/prothrombin immunoglobulin M antibodies were 14.2 ±8.7, 6.7 ±6.4 and 12.4 ±15.5 absorbance units in groups 1, 2 and 3 respectively (P <0.0001), with 7.1%, 3.4% and 9.9% of groups 1, 2 and 3 positive for the antibody. Mean optical density levels of serum antiprothrombin and antiphospholipid immunoglobulin G antibodies were higher in groups 1 and 3 compared with 2 (P <0.005) and in groups 1 and 2 compared with 3 (P <0.01), respectively. Groups 1, 2 and 3 were positive for antiphospholipid immunoglobulin G antibodies (groups 1 and 2 compared with 3) . Celiac disease sera harbor a higher antiprothrombin immunoglobulin G level compared with controls.

Conclusions

It is suggested that the intestinal injury, endothelial dysfunction, platelet abnormality and enhanced apoptosis recently described in celiac disease are at the origin of the increased exposure of phospholipids or new epitopes representing autoantigens. Those autoantibodies might play a pathogenic role in the thrombophilia associated with celiac disease and represent markers for potential anticoagulant preventive therapy.
Literature
1.
go back to reference Lerner A, Blank M, Shoenfeld Y: Celiac disease and autoimmunity. Isr J Med Sci. 1996, 32: 33-36.PubMed Lerner A, Blank M, Shoenfeld Y: Celiac disease and autoimmunity. Isr J Med Sci. 1996, 32: 33-36.PubMed
2.
go back to reference Reif S, Lerner A: Tissue transglutaminase – the key player in celiac disease: a review. Autoimm Rev. 2004, 3: 40-45. 10.1016/S1568-9972(03)00065-X.CrossRef Reif S, Lerner A: Tissue transglutaminase – the key player in celiac disease: a review. Autoimm Rev. 2004, 3: 40-45. 10.1016/S1568-9972(03)00065-X.CrossRef
3.
go back to reference Shamir R, Eliakim R, Lahat N, Sobel E, Lerner A: ELISA assay of anti endomysial antibodies in the diagnosis of celiac disease: comparison with immunofluorescence assay of anti endomysial antibodies and tissue transglutaminase antibodies. Isr Med Assoc J. 2002, 4: 594-596.PubMed Shamir R, Eliakim R, Lahat N, Sobel E, Lerner A: ELISA assay of anti endomysial antibodies in the diagnosis of celiac disease: comparison with immunofluorescence assay of anti endomysial antibodies and tissue transglutaminase antibodies. Isr Med Assoc J. 2002, 4: 594-596.PubMed
4.
go back to reference Rozenberg O, Lerner A, Pacht A, Grinberg M, Reginashvili D, Henig C, Barak M: A novel algorithm for childhood celiac disease serological diagnosis based upon intestinal biopsies. Crit Rev Allerg Immunol. 2012, 42: 331-341. 10.1007/s12016-010-8250-y.CrossRef Rozenberg O, Lerner A, Pacht A, Grinberg M, Reginashvili D, Henig C, Barak M: A novel algorithm for childhood celiac disease serological diagnosis based upon intestinal biopsies. Crit Rev Allerg Immunol. 2012, 42: 331-341. 10.1007/s12016-010-8250-y.CrossRef
5.
go back to reference Lerner A: New therapeutic strategies for celiac disease. Autoimmun Rev. 2010, 9: 144-147. 10.1016/j.autrev.2009.05.002.CrossRefPubMed Lerner A: New therapeutic strategies for celiac disease. Autoimmun Rev. 2010, 9: 144-147. 10.1016/j.autrev.2009.05.002.CrossRefPubMed
6.
go back to reference Lerner A: Factors affecting the clinical presentation and time diagnosis of celiac disease: The Jerusalem and the West Bank-Gaza experience. Isr J Med Sci. 1994, 30: 294-295.PubMed Lerner A: Factors affecting the clinical presentation and time diagnosis of celiac disease: The Jerusalem and the West Bank-Gaza experience. Isr J Med Sci. 1994, 30: 294-295.PubMed
7.
go back to reference Branski D, Ashkenazy A, Frier S, Lerner A, Dinari G, Faber J, Bujanover Y, Jonas A, Lebental E: Extra intestinal manifestation and associated disorders of celiac disease. Gluten-Sensitive Enteropathy from Gastrointest Res. Edited by: Branski D, Rozen P, Kaganoff MF. 1992, Basel, Switzerland: Karger, 164-175. Branski D, Ashkenazy A, Frier S, Lerner A, Dinari G, Faber J, Bujanover Y, Jonas A, Lebental E: Extra intestinal manifestation and associated disorders of celiac disease. Gluten-Sensitive Enteropathy from Gastrointest Res. Edited by: Branski D, Rozen P, Kaganoff MF. 1992, Basel, Switzerland: Karger, 164-175.
8.
go back to reference Zelnik N, Pacht A, Obeid R, Lerner A: Range of neurological disorders in patients with celiac disease. Pediatrics. 2004, 113: 1672-1676. 10.1542/peds.113.6.1672.CrossRefPubMed Zelnik N, Pacht A, Obeid R, Lerner A: Range of neurological disorders in patients with celiac disease. Pediatrics. 2004, 113: 1672-1676. 10.1542/peds.113.6.1672.CrossRefPubMed
9.
go back to reference Blazina S, Bratanic N, Campa AS, Blagus R, Orel R: Bone mineral density and importance of strict gluten-free diet in children and adolescents with celiac disease. Bone. 2012, 47: 598-603.CrossRef Blazina S, Bratanic N, Campa AS, Blagus R, Orel R: Bone mineral density and importance of strict gluten-free diet in children and adolescents with celiac disease. Bone. 2012, 47: 598-603.CrossRef
10.
go back to reference El Moutawakil B, Chourkani N, Sibai M, Moutaouakil F, Rafai M, Bourezgui M, Slassi I: Celiac disease and ischemic stroke. Rev Neuro (Paris). 2009, 165: 962-966. 10.1016/j.neurol.2008.09.002.CrossRef El Moutawakil B, Chourkani N, Sibai M, Moutaouakil F, Rafai M, Bourezgui M, Slassi I: Celiac disease and ischemic stroke. Rev Neuro (Paris). 2009, 165: 962-966. 10.1016/j.neurol.2008.09.002.CrossRef
11.
go back to reference Audia S, Duchene C, Samson M, Muller G, Bielefeld P, Ricolfi F, Giroud M, Besancenot JF: Stroke in young adults with celiac disease. Rev Med Interne. 2008, 29: 228-231. 10.1016/j.revmed.2007.08.013.CrossRefPubMed Audia S, Duchene C, Samson M, Muller G, Bielefeld P, Ricolfi F, Giroud M, Besancenot JF: Stroke in young adults with celiac disease. Rev Med Interne. 2008, 29: 228-231. 10.1016/j.revmed.2007.08.013.CrossRefPubMed
12.
go back to reference Goodwin FC, Beattie RM, Millar J, Kirkham FJ: Celiac disease and childhood stroke. Pediatr Neurol. 2004, 31: 139-142. 10.1016/j.pediatrneurol.2004.02.014.CrossRefPubMed Goodwin FC, Beattie RM, Millar J, Kirkham FJ: Celiac disease and childhood stroke. Pediatr Neurol. 2004, 31: 139-142. 10.1016/j.pediatrneurol.2004.02.014.CrossRefPubMed
13.
go back to reference Belfkih R, Souirti Z, Chtaou N, Messouak O, Belahsen F: Accident vasculaire cerebral ischemique revelant une maladie coeliaque. Pan African Med J. 2010, 5: 2-7. Belfkih R, Souirti Z, Chtaou N, Messouak O, Belahsen F: Accident vasculaire cerebral ischemique revelant une maladie coeliaque. Pan African Med J. 2010, 5: 2-7.
14.
go back to reference Ludvigsson JF, West J, Card T, Appelros P: Risk of stroke in 28000 patients with celiac disease: a nationwide cohort study in Sweden. J Stroke Cerebrovascular Dis. 2012, 21: 860-867. 10.1016/j.jstrokecerebrovasdis.2011.05.008.CrossRef Ludvigsson JF, West J, Card T, Appelros P: Risk of stroke in 28000 patients with celiac disease: a nationwide cohort study in Sweden. J Stroke Cerebrovascular Dis. 2012, 21: 860-867. 10.1016/j.jstrokecerebrovasdis.2011.05.008.CrossRef
15.
go back to reference Ludvigsson JF, Welander A, Lassila R, Ekbom A, Montgomery SM: Risk of thromboembolism in 14000 individuals with celiac disease. Br J Haematol. 2007, 139: 121-127. 10.1111/j.1365-2141.2007.06766.x.CrossRefPubMed Ludvigsson JF, Welander A, Lassila R, Ekbom A, Montgomery SM: Risk of thromboembolism in 14000 individuals with celiac disease. Br J Haematol. 2007, 139: 121-127. 10.1111/j.1365-2141.2007.06766.x.CrossRefPubMed
16.
go back to reference Ciacci C, Tortora R, Scudiero O, Di Fiore R, Salvatore F, Castaldo G: Early pregnancy loss in celiac women: the role of genetic markers of thrombophilia. Dig Liver Dis. 2009, 41: 717-720. 10.1016/j.dld.2009.02.050.CrossRefPubMed Ciacci C, Tortora R, Scudiero O, Di Fiore R, Salvatore F, Castaldo G: Early pregnancy loss in celiac women: the role of genetic markers of thrombophilia. Dig Liver Dis. 2009, 41: 717-720. 10.1016/j.dld.2009.02.050.CrossRefPubMed
17.
go back to reference Baryshnikov EN, Krums LM, Vorobeva NN, Parfenov AL: Lower extremity deep vein thrombosis associated with gluten-sensitivity celiac disease. Ter Arkh. 2010, 82: 52-54.PubMed Baryshnikov EN, Krums LM, Vorobeva NN, Parfenov AL: Lower extremity deep vein thrombosis associated with gluten-sensitivity celiac disease. Ter Arkh. 2010, 82: 52-54.PubMed
18.
19.
go back to reference Emilsson LE, Smith JG, West J, Melander O, Ludvigsson JF: Increased risk of atrial fibrillation in patients with celiac disease: a nationwide cohort study. Europ Heart J. 2011, 32: 2430-2437. 10.1093/eurheartj/ehr167.CrossRef Emilsson LE, Smith JG, West J, Melander O, Ludvigsson JF: Increased risk of atrial fibrillation in patients with celiac disease: a nationwide cohort study. Europ Heart J. 2011, 32: 2430-2437. 10.1093/eurheartj/ehr167.CrossRef
20.
go back to reference Afredj N, Metatla S, Faraoun SA, Nani A, Guessab N, Benhalima M, Bendib SE, Debzi N, Layaida K, Gamar L, Baiod N, Balamane M, Kaddache N, Bounab N, Kecili L, Boucekkine T: Association of Budd-Chiari syndrome and celiac disease. Gastroenterol Clin Biol. 2010, 34: 621-624. 10.1016/j.gcb.2010.07.007.CrossRefPubMed Afredj N, Metatla S, Faraoun SA, Nani A, Guessab N, Benhalima M, Bendib SE, Debzi N, Layaida K, Gamar L, Baiod N, Balamane M, Kaddache N, Bounab N, Kecili L, Boucekkine T: Association of Budd-Chiari syndrome and celiac disease. Gastroenterol Clin Biol. 2010, 34: 621-624. 10.1016/j.gcb.2010.07.007.CrossRefPubMed
21.
go back to reference Kremer Hovinga JA, Baerlocher G, Wuillemin WA, Solenthaler M: Deep venous thrombosis of the leg in acquired thrombophilia-hyperhomocysteinemia as a sequela of undetected celiac disease. Rev Therapeutique. 1999, 56: 519-522. Kremer Hovinga JA, Baerlocher G, Wuillemin WA, Solenthaler M: Deep venous thrombosis of the leg in acquired thrombophilia-hyperhomocysteinemia as a sequela of undetected celiac disease. Rev Therapeutique. 1999, 56: 519-522.
22.
go back to reference Hozyasz KK, Mostowska A, Szaflarska-Poplawaka A, Lianeri M, Jagodzinski PP: Polymorphic variants of genes involved in homocysteine metabolism in celiac disease. Mol Biol Rep. 2012, 39: 3123-3130. 10.1007/s11033-011-1077-7.CrossRefPubMed Hozyasz KK, Mostowska A, Szaflarska-Poplawaka A, Lianeri M, Jagodzinski PP: Polymorphic variants of genes involved in homocysteine metabolism in celiac disease. Mol Biol Rep. 2012, 39: 3123-3130. 10.1007/s11033-011-1077-7.CrossRefPubMed
23.
go back to reference Wilcox GM, Mattia AR: Celiac sprue, hyperhomocysteinemia, and MTHFR gene variants. J Clin Gastroenterol. 2006, 40: 596-601. 10.1097/00004836-200608000-00007.CrossRefPubMed Wilcox GM, Mattia AR: Celiac sprue, hyperhomocysteinemia, and MTHFR gene variants. J Clin Gastroenterol. 2006, 40: 596-601. 10.1097/00004836-200608000-00007.CrossRefPubMed
24.
go back to reference Dickey W, Ward M, Whittle CR, Kelly MT, Pentieva K, Horigan G, Patton S, McNulty H: Homocysteine and related B-vitamin status in celiac disease: effects of gluten exclusion and histological recovery. Scand J Gastroenterol. 2008, 43: 682-688. 10.1080/00365520701881118.CrossRefPubMed Dickey W, Ward M, Whittle CR, Kelly MT, Pentieva K, Horigan G, Patton S, McNulty H: Homocysteine and related B-vitamin status in celiac disease: effects of gluten exclusion and histological recovery. Scand J Gastroenterol. 2008, 43: 682-688. 10.1080/00365520701881118.CrossRefPubMed
25.
go back to reference Casella G, Bassotti G, Villanacci V, Di Bella C, Pagni F, Corti GL, Sabatino G, Piatti M, Baldini V: Is hyperhomocysteinemia relevant in patients with celiac disease?. World J Gastroenterol. 2011, 17: 2941-2944. 10.3748/wjg.v17.i24.2941.CrossRefPubMedPubMedCentral Casella G, Bassotti G, Villanacci V, Di Bella C, Pagni F, Corti GL, Sabatino G, Piatti M, Baldini V: Is hyperhomocysteinemia relevant in patients with celiac disease?. World J Gastroenterol. 2011, 17: 2941-2944. 10.3748/wjg.v17.i24.2941.CrossRefPubMedPubMedCentral
26.
go back to reference Hallert C, Grant C, Grehn S, Grännö C, Hultén S, Midhagen G, Ström M, Svensson H, Valdimarsson T: Evidence of poor vitamin status in celiac patients on a gluten-free diet for 10 years. Aliment Therap. 2002, 16: 1333-1339. 10.1046/j.1365-2036.2002.01283.x.CrossRef Hallert C, Grant C, Grehn S, Grännö C, Hultén S, Midhagen G, Ström M, Svensson H, Valdimarsson T: Evidence of poor vitamin status in celiac patients on a gluten-free diet for 10 years. Aliment Therap. 2002, 16: 1333-1339. 10.1046/j.1365-2036.2002.01283.x.CrossRef
27.
go back to reference Lerner A, Blank M, Shoenfeld Y: Increased prevalence of autoantibodies in celiac disease. Dig Dis Sci. 1998, 43: 723-726. 10.1023/A:1018801711413.CrossRefPubMed Lerner A, Blank M, Shoenfeld Y: Increased prevalence of autoantibodies in celiac disease. Dig Dis Sci. 1998, 43: 723-726. 10.1023/A:1018801711413.CrossRefPubMed
28.
go back to reference Shaoul R, Lerner A: Associated autoantibodies in celiac disease. Autoimmun Rev. 2007, 6: 559-565. 10.1016/j.autrev.2007.02.006.CrossRefPubMed Shaoul R, Lerner A: Associated autoantibodies in celiac disease. Autoimmun Rev. 2007, 6: 559-565. 10.1016/j.autrev.2007.02.006.CrossRefPubMed
29.
go back to reference Swissa M, Lerner A, Sasaki T, Sela E, Blank M, Shoenfeld Y: The diverse pathogenic potential of anti-DNA antibodies from various sources to induce experimental systemic lupus erythematosus. Pathobiology. 1996, 64: 32-39. 10.1159/000164003.CrossRefPubMed Swissa M, Lerner A, Sasaki T, Sela E, Blank M, Shoenfeld Y: The diverse pathogenic potential of anti-DNA antibodies from various sources to induce experimental systemic lupus erythematosus. Pathobiology. 1996, 64: 32-39. 10.1159/000164003.CrossRefPubMed
30.
go back to reference Shamir R, Shoenfeld Y, Blank M, Eliakim R, Lahat N, Sobel E, Shinar E, Lerner A: The prevalence of coeliac disease antibodies in patients with the antiphospholipid syndrome. Lupus. 2003, 12: 394-399. 10.1191/0961203303lu384oa.CrossRefPubMed Shamir R, Shoenfeld Y, Blank M, Eliakim R, Lahat N, Sobel E, Shinar E, Lerner A: The prevalence of coeliac disease antibodies in patients with the antiphospholipid syndrome. Lupus. 2003, 12: 394-399. 10.1191/0961203303lu384oa.CrossRefPubMed
31.
go back to reference Nojima J, Iwatani Y, Suehisa E, Kuratsune H, Kanakura Y: The presence of anti-phosphatidyle/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus. Haematologica. 2006, 91: 699-702.PubMed Nojima J, Iwatani Y, Suehisa E, Kuratsune H, Kanakura Y: The presence of anti-phosphatidyle/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus. Haematologica. 2006, 91: 699-702.PubMed
32.
go back to reference Bertolaccini ML, Gomez S, Pareja JF, Theodoridou A, Sanna G, Hughes GR, Khamashta MA: Antiphospholipid antibody tests: spreading the net. Ann Rheum Dis. 2005, 64: 1639-1643. 10.1136/ard.2005.035824.CrossRefPubMedPubMedCentral Bertolaccini ML, Gomez S, Pareja JF, Theodoridou A, Sanna G, Hughes GR, Khamashta MA: Antiphospholipid antibody tests: spreading the net. Ann Rheum Dis. 2005, 64: 1639-1643. 10.1136/ard.2005.035824.CrossRefPubMedPubMedCentral
33.
go back to reference Tsutsumi A, Hayashi T, Chino Y, Mamura M, Goto D, Matsumoto I, Ito S, Sumida T: Significance of antithrombin antibodies in patients with systemic lupus erythematosus: clinical evaluation of the antithrombin assay and the antiphosphatidylserine/prothrombin assay, and comparison with other antiphospholipid antibody assays. Mod Rheumatol. 2006, 16: 158-164. 10.1007/s10165-006-0481-7.CrossRefPubMedPubMedCentral Tsutsumi A, Hayashi T, Chino Y, Mamura M, Goto D, Matsumoto I, Ito S, Sumida T: Significance of antithrombin antibodies in patients with systemic lupus erythematosus: clinical evaluation of the antithrombin assay and the antiphosphatidylserine/prothrombin assay, and comparison with other antiphospholipid antibody assays. Mod Rheumatol. 2006, 16: 158-164. 10.1007/s10165-006-0481-7.CrossRefPubMedPubMedCentral
34.
go back to reference Atsumi T, Koike T: Clinical relevance of antiprothrombin antibodies. Autoimmun Rev. 2002, 1: 49-53. 10.1016/S1568-9972(01)00006-4.CrossRefPubMed Atsumi T, Koike T: Clinical relevance of antiprothrombin antibodies. Autoimmun Rev. 2002, 1: 49-53. 10.1016/S1568-9972(01)00006-4.CrossRefPubMed
35.
go back to reference Atsumi T, Ieko M, Bertolaccini ML, Ichikawa K, Tsutsumi A, Matsuura E, Koike T: Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthr Rheumatism. 2000, 43: 1982-1993. 10.1002/1529-0131(200009)43:9<1982::AID-ANR9>3.0.CO;2-2.CrossRef Atsumi T, Ieko M, Bertolaccini ML, Ichikawa K, Tsutsumi A, Matsuura E, Koike T: Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthr Rheumatism. 2000, 43: 1982-1993. 10.1002/1529-0131(200009)43:9<1982::AID-ANR9>3.0.CO;2-2.CrossRef
36.
go back to reference Sakai Y, Atsumi T, Ieko M, Amengual O, Furukawa S, Furusaki A, Bohgaki M, Kataoka H, Horita T, Yasuda S, Koike T: The effects of phosphatidylserine-dependent antiprothrombin antibody on thrombin generation. Arthr Rheumatism. 2009, 60: 2457-2467. 10.1002/art.24708.CrossRef Sakai Y, Atsumi T, Ieko M, Amengual O, Furukawa S, Furusaki A, Bohgaki M, Kataoka H, Horita T, Yasuda S, Koike T: The effects of phosphatidylserine-dependent antiprothrombin antibody on thrombin generation. Arthr Rheumatism. 2009, 60: 2457-2467. 10.1002/art.24708.CrossRef
37.
go back to reference Nojima J, Kuratsune H, Suehisa E, Iwatani Y, Kanakura Y: Acquired activated protein C resistance associated with IgG antibodies against β2-glycoprotein І and prothrombin as a strong risk factor for venous thromboembolism. Clin Chem. 2005, 51: 545-552. 10.1373/clinchem.2004.043414.CrossRefPubMed Nojima J, Kuratsune H, Suehisa E, Iwatani Y, Kanakura Y: Acquired activated protein C resistance associated with IgG antibodies against β2-glycoprotein І and prothrombin as a strong risk factor for venous thromboembolism. Clin Chem. 2005, 51: 545-552. 10.1373/clinchem.2004.043414.CrossRefPubMed
38.
go back to reference Nojima J, Kuratsune H, Suehisa E, Kitani T, Iwatani Y, Kanakura Y: Strong correlation between the prevalence of cerebral infarction and the presence of anti-cardiolipin/beta2-glycoprotein І and anti-phosphatidylserine/prothrombin antibodies - co-existence of these antibodies anhances ADP-induced platelet activation in vitro. Thromb Haemost. 2004, 91: 967-976.PubMed Nojima J, Kuratsune H, Suehisa E, Kitani T, Iwatani Y, Kanakura Y: Strong correlation between the prevalence of cerebral infarction and the presence of anti-cardiolipin/beta2-glycoprotein І and anti-phosphatidylserine/prothrombin antibodies - co-existence of these antibodies anhances ADP-induced platelet activation in vitro. Thromb Haemost. 2004, 91: 967-976.PubMed
39.
go back to reference Descloux E, Durieu I, Cochat P, Vital Durand D, Ninet J, Fabien N, Cimaz R: Pediatric systemic lupus erythematosus: prognostic impact of antiphospholipid antibodies. Rheumatol (Oxford). 2008, 47: 183-187.CrossRef Descloux E, Durieu I, Cochat P, Vital Durand D, Ninet J, Fabien N, Cimaz R: Pediatric systemic lupus erythematosus: prognostic impact of antiphospholipid antibodies. Rheumatol (Oxford). 2008, 47: 183-187.CrossRef
40.
go back to reference Okuma H, Kitagawa Y, Ishikawa T, Takagi S: Study of phosphatidylserine-dependent anti-prothrombin antibody in cerebral infarction. Inter Med. 2009, 48: 1351-1355. 10.2169/internalmedicine.48.2232.CrossRef Okuma H, Kitagawa Y, Ishikawa T, Takagi S: Study of phosphatidylserine-dependent anti-prothrombin antibody in cerebral infarction. Inter Med. 2009, 48: 1351-1355. 10.2169/internalmedicine.48.2232.CrossRef
41.
go back to reference Bertolaccini ML, Atsumi T, Koike T, Hughes GR, Khamashta MA: Antiprothrombin antibodies detected in two different assay systems. Prevalence and clinical significance in systemic lupus erythematosus. Thromb Haemost. 2005, 93: 289-297.PubMed Bertolaccini ML, Atsumi T, Koike T, Hughes GR, Khamashta MA: Antiprothrombin antibodies detected in two different assay systems. Prevalence and clinical significance in systemic lupus erythematosus. Thromb Haemost. 2005, 93: 289-297.PubMed
42.
go back to reference Galli M, Luciani D, Bertolini G, Barbui T: Anti- β2-glycoprotein І, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood. 2003, 102: 2717-2723. 10.1182/blood-2002-11-3334.CrossRefPubMed Galli M, Luciani D, Bertolini G, Barbui T: Anti- β2-glycoprotein І, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood. 2003, 102: 2717-2723. 10.1182/blood-2002-11-3334.CrossRefPubMed
43.
go back to reference Hoxha A, Ruffatti A, Tonello M, Bontadi A, Salvan E, Banzata A, Pengo V, Punzi L: Antiphosphatidylserine/prothrombin antibodies in primary antiphospholipid syndrome. Lupus. 2012, 21: 787-789. 10.1177/0961203312441983.CrossRefPubMed Hoxha A, Ruffatti A, Tonello M, Bontadi A, Salvan E, Banzata A, Pengo V, Punzi L: Antiphosphatidylserine/prothrombin antibodies in primary antiphospholipid syndrome. Lupus. 2012, 21: 787-789. 10.1177/0961203312441983.CrossRefPubMed
44.
go back to reference Hoxha A, Ruffatti A, Pittoni M, Bontadi A, Tonello M, Salvan E, Plebani M, Punzi L: The clinical significance of autoantibodies directed against prothrombin in primary antiphospholipid syndrome. Clin Chim Acta. 2012, 413: 911-913. 10.1016/j.cca.2012.02.004.CrossRefPubMed Hoxha A, Ruffatti A, Pittoni M, Bontadi A, Tonello M, Salvan E, Plebani M, Punzi L: The clinical significance of autoantibodies directed against prothrombin in primary antiphospholipid syndrome. Clin Chim Acta. 2012, 413: 911-913. 10.1016/j.cca.2012.02.004.CrossRefPubMed
45.
go back to reference Walker-Smith JA, Guandalini S, Schmitz J, Shmerling DH, Visakorpi JK: Revised criteria for the diagnosis of celiac disease. Report of the working group of European Society of Pediatric Gastroenterology and nutrition. Arch Dis Child. 1990, 65: 909-911.CrossRef Walker-Smith JA, Guandalini S, Schmitz J, Shmerling DH, Visakorpi JK: Revised criteria for the diagnosis of celiac disease. Report of the working group of European Society of Pediatric Gastroenterology and nutrition. Arch Dis Child. 1990, 65: 909-911.CrossRef
46.
go back to reference Rozenberg O, Lerner A, Pacht A, Grinberg M, Reginashvili D, Henig C, Barak M: A new algorithm for the diagnosis of celiac disease. Cell Mol Immunol. 2011, 8: 146-149. 10.1038/cmi.2010.63.CrossRefPubMedPubMedCentral Rozenberg O, Lerner A, Pacht A, Grinberg M, Reginashvili D, Henig C, Barak M: A new algorithm for the diagnosis of celiac disease. Cell Mol Immunol. 2011, 8: 146-149. 10.1038/cmi.2010.63.CrossRefPubMedPubMedCentral
47.
go back to reference da Rosa Utiyama SR, da Silva Kotze LM, Nisihara RM, Carvalho RF, de Carvalho EG, de Sena MG, de Messias Reason IJ: Spectrum of autoantibodies in celiac patients and relatives. Dig Dis Sci. 2001, 46: 2624-2630. 10.1023/A:1012702807714.CrossRefPubMed da Rosa Utiyama SR, da Silva Kotze LM, Nisihara RM, Carvalho RF, de Carvalho EG, de Sena MG, de Messias Reason IJ: Spectrum of autoantibodies in celiac patients and relatives. Dig Dis Sci. 2001, 46: 2624-2630. 10.1023/A:1012702807714.CrossRefPubMed
48.
go back to reference Petaros P, Martelossi S, Tommasini A, Torre G, Caradonna M, Ventura A: Prevalence of autoimmune disorders in relatives of patients with celiac disease. Dig Dis Sci. 2002, 47: 1427-1431. 10.1023/A:1015830110836.CrossRefPubMed Petaros P, Martelossi S, Tommasini A, Torre G, Caradonna M, Ventura A: Prevalence of autoimmune disorders in relatives of patients with celiac disease. Dig Dis Sci. 2002, 47: 1427-1431. 10.1023/A:1015830110836.CrossRefPubMed
49.
go back to reference Cataldo F, Marino V: Increased prevalence of autoimmune diseases in first-degree relatives of patients with celiac disease. J Pedietr Gastroenterol Nutr. 2003, 36: 470-473. 10.1097/00005176-200304000-00009.CrossRef Cataldo F, Marino V: Increased prevalence of autoimmune diseases in first-degree relatives of patients with celiac disease. J Pedietr Gastroenterol Nutr. 2003, 36: 470-473. 10.1097/00005176-200304000-00009.CrossRef
50.
go back to reference Puurunen M, Vaarala O, Julkunen H, Aho K, Palosuo T: Antibodies to phospholipid-binding plasma proteins and occurrence of thrombosis in patients with systemic lupus erythematosus. Clin Immunol Immunopathol. 1996, 80: 16-22. 10.1006/clin.1996.0089.CrossRefPubMed Puurunen M, Vaarala O, Julkunen H, Aho K, Palosuo T: Antibodies to phospholipid-binding plasma proteins and occurrence of thrombosis in patients with systemic lupus erythematosus. Clin Immunol Immunopathol. 1996, 80: 16-22. 10.1006/clin.1996.0089.CrossRefPubMed
51.
go back to reference Bertolaccini ML, Atsumi T, Khamashta MA, Amengual O, Hughes GR: Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus. J Rheumatol. 1998, 25: 1104-1108.PubMed Bertolaccini ML, Atsumi T, Khamashta MA, Amengual O, Hughes GR: Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus. J Rheumatol. 1998, 25: 1104-1108.PubMed
52.
go back to reference Vaarala O, Puurunen M, Manttari M, Manninen V, Aho K, Palosuo T: Autoantibodies to prothrombin imply a risk of myocardial infarction in middle-aged men. Thromb Haemost. 1996, 75: 456-459.PubMed Vaarala O, Puurunen M, Manttari M, Manninen V, Aho K, Palosuo T: Autoantibodies to prothrombin imply a risk of myocardial infarction in middle-aged men. Thromb Haemost. 1996, 75: 456-459.PubMed
53.
go back to reference Palosuo T, Virtamo J, Haukka J, Taylor PR, Aho K, Puurunen M, Vaarala O: High antibody levels to prothrombin imply a risk of deep venous thrombosis and pulmonary embolism in middle-aged men. A nested case–control study. Thrombo Haemost. 1997, 78: 1178-1182. Palosuo T, Virtamo J, Haukka J, Taylor PR, Aho K, Puurunen M, Vaarala O: High antibody levels to prothrombin imply a risk of deep venous thrombosis and pulmonary embolism in middle-aged men. A nested case–control study. Thrombo Haemost. 1997, 78: 1178-1182.
54.
go back to reference Berthoux E, Fabien N, Chayvialle JA, Ninet J, Durieu I: Adult celiac disease with thrombosis: a case series of seven patients. Role of thrombophilic factors. Rev Med Interne. 2011, 32: 600-604. 10.1016/j.revmed.2011.02.025.CrossRefPubMed Berthoux E, Fabien N, Chayvialle JA, Ninet J, Durieu I: Adult celiac disease with thrombosis: a case series of seven patients. Role of thrombophilic factors. Rev Med Interne. 2011, 32: 600-604. 10.1016/j.revmed.2011.02.025.CrossRefPubMed
55.
go back to reference Austin A, Campbell E, Lane P, Elias E: Nodular regenerative hyperplasia of the liver and celiac disease: potential role of IgA anticardiolipin antibody. Gut. 2004, 53: 1032-1034. 10.1136/gut.2003.036806.CrossRefPubMedPubMedCentral Austin A, Campbell E, Lane P, Elias E: Nodular regenerative hyperplasia of the liver and celiac disease: potential role of IgA anticardiolipin antibody. Gut. 2004, 53: 1032-1034. 10.1136/gut.2003.036806.CrossRefPubMedPubMedCentral
56.
go back to reference D'Agnillo P, Levine JS, Subang R, Rauch J: Prothrombin binds to the surface of apoptotic, but not viable, cells and serves as a target of lupus anticoagulant autoantibodies. J Immunol. 2003, 170: 3408-3422.CrossRefPubMed D'Agnillo P, Levine JS, Subang R, Rauch J: Prothrombin binds to the surface of apoptotic, but not viable, cells and serves as a target of lupus anticoagulant autoantibodies. J Immunol. 2003, 170: 3408-3422.CrossRefPubMed
57.
go back to reference Price BE, Rauch J, Shia MA, Walsh MT, Lieberthal W, Gilligan HM, O'Laughlin T, Koh JS, Levine JS: Anti-phospholipid autoantibodies bind to apoptotic, but not viable, thymocytes in a 2-glycoprotein-dependent manner. J Immunol. 1996, 157: 2201-2208.PubMed Price BE, Rauch J, Shia MA, Walsh MT, Lieberthal W, Gilligan HM, O'Laughlin T, Koh JS, Levine JS: Anti-phospholipid autoantibodies bind to apoptotic, but not viable, thymocytes in a 2-glycoprotein-dependent manner. J Immunol. 1996, 157: 2201-2208.PubMed
58.
go back to reference Ieko M, Nakabayashi T, Tarumi T, Yoshida M, Naito S, Atsumi T, Koike T: Phosphatidylserine-dependent anti-prothrombin antibody as a new marker for the diagnosis of antiphosphlipid syndrome. Rinsho Byori. 2006, 5 (4): 256-262. Ieko M, Nakabayashi T, Tarumi T, Yoshida M, Naito S, Atsumi T, Koike T: Phosphatidylserine-dependent anti-prothrombin antibody as a new marker for the diagnosis of antiphosphlipid syndrome. Rinsho Byori. 2006, 5 (4): 256-262.
59.
go back to reference Picarelli A, Di Tola M, Sabbatella L, Mercuri V, Pietrobono D, Bassotti G, D'Amico T, Donato G, Picarelli G, Marino M, Borghini R, Centanni M, Gargiulo P: Type 1 diabetes mellitus and celiac disease: endothelial dysfunction. Acta Diabetol. 2011, [Epub ahead of print] Picarelli A, Di Tola M, Sabbatella L, Mercuri V, Pietrobono D, Bassotti G, D'Amico T, Donato G, Picarelli G, Marino M, Borghini R, Centanni M, Gargiulo P: Type 1 diabetes mellitus and celiac disease: endothelial dysfunction. Acta Diabetol. 2011, [Epub ahead of print]
60.
go back to reference Foley S, Garsed K, Singh G, Duroudier NP, Swan C, Hall IP, Zaitoun A, Bennett A, Marsden C, Holmes G, Walls A, Spiller RC: Impaired uptake of serotonin by platelets from patients with irritable bowel syndrome correlates with duodenal immune activation. Gastroenterol. 2011, 140: 1434-1443. 10.1053/j.gastro.2011.01.052.CrossRef Foley S, Garsed K, Singh G, Duroudier NP, Swan C, Hall IP, Zaitoun A, Bennett A, Marsden C, Holmes G, Walls A, Spiller RC: Impaired uptake of serotonin by platelets from patients with irritable bowel syndrome correlates with duodenal immune activation. Gastroenterol. 2011, 140: 1434-1443. 10.1053/j.gastro.2011.01.052.CrossRef
61.
go back to reference Coleman NS, Foley S, Dunlop SP, Wheatcroft J, Blackshaw E, Perkins AC, Singh G, Marsden CA, Holmes GK, Spiller RC: Abnormalities of serotonin metabolism and their relation to symptoms in untreated celiac disease. Clin Gastroenterol Hepatol. 2006, 4: 874-881. 10.1016/j.cgh.2006.04.017.CrossRefPubMed Coleman NS, Foley S, Dunlop SP, Wheatcroft J, Blackshaw E, Perkins AC, Singh G, Marsden CA, Holmes GK, Spiller RC: Abnormalities of serotonin metabolism and their relation to symptoms in untreated celiac disease. Clin Gastroenterol Hepatol. 2006, 4: 874-881. 10.1016/j.cgh.2006.04.017.CrossRefPubMed
62.
go back to reference Mazzarella G, Stefanile R, Camarca A, Giliberti P, Cosentini E, Marano C, Iaquinto G, Giardullo N, Auricchio S, Sette A, Troncone R, Gianfrani C: Gliadin activates HLA class 1-restricted CD8+ cells in celiac disease intestinal mucosa and induces the enterocyte apoptosis. Gastroenterol. 2008, 134: 1017-1027. 10.1053/j.gastro.2008.01.008.CrossRef Mazzarella G, Stefanile R, Camarca A, Giliberti P, Cosentini E, Marano C, Iaquinto G, Giardullo N, Auricchio S, Sette A, Troncone R, Gianfrani C: Gliadin activates HLA class 1-restricted CD8+ cells in celiac disease intestinal mucosa and induces the enterocyte apoptosis. Gastroenterol. 2008, 134: 1017-1027. 10.1053/j.gastro.2008.01.008.CrossRef
63.
go back to reference Lipinski S, Bremer L, Lammers T, Thieme F, Schreiber S, Rosenstiel P: Coagulation and inflammation, Molecular insights and diagnostic implications. Hamostaseologie. 2011, 31: 94-104.CrossRefPubMed Lipinski S, Bremer L, Lammers T, Thieme F, Schreiber S, Rosenstiel P: Coagulation and inflammation, Molecular insights and diagnostic implications. Hamostaseologie. 2011, 31: 94-104.CrossRefPubMed
Metadata
Title
The thrombophilic network of autoantibodies in celiac disease
Authors
Aaron Lerner
Nancy Agmon-Levin
Yinon Shapira
Boris Gilburd
Sandra Reuter
Idit Lavi
Yehuda Shoenfeld
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Medicine / Issue 1/2013
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/1741-7015-11-89

Other articles of this Issue 1/2013

BMC Medicine 1/2013 Go to the issue